Updates in Oncology: Oral Presentations from the NCCN Poster Sessions
Approved research abstracts were presented during NCCN Annual Conference Poster Sessions. Topic areas for posters include: Clinical Oncology (all phases), Pre-Clinical Oncology, Epidemiology/Risks/Prevention, Correlative/Genomic, Best Practices in Implementation and Use of Clinical Practice Guidelines, Quality Improvement, Outcomes and Health Services Research (including equity and disparities), and BIOinformatics/Information Technology Sciences. The seven top-rated abstracts are showcased here.
Target Audience
This educational program is designed to meet the educational needs of physicians/oncologists, nurse practitioners, nurses, physician assistants, pharmacists, and other health care professionals who manage patients with cancer.
Learning Objectives
Following this program, participants should be able to:
- Review the results of oncology research as presented in the seven top-rated posters.
Wui-Jin Koh, MD
National Comprehensive Cancer Network
Lifen Cao, MD, PhD
University Hospitals Cleveland Medical Center, Case Western Reserve University
Peter G. Doukas, MD
Northwestern University Feinberg School of Medicine
Joshua W. Goyert, MS
University of Michigan Medical School
Ping Jiang, PhD
Peking University Third Hospital
Priyanka Reddy, MD
Case Western Reserve University Hospital: University Hospitals
Sri Harsha Tella, MBBS, FACP
Mayo Clinic Cancer Center
Ami Vyas, PhD, MS, MBA
University of Rhode Island
NCCN Continuing Education Disclosure Policy
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates, and discloses to learners all relevant financial relationships.
In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing.
Definitions
Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.
Faculty Disclaimers
All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.
Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.
Faculty Disclosures
Primary Authors and Co-Authors: Oral Presentations from the NCCN Poster Session
The faculty listed below have no relevant financial relationship(s) with ineligible companies to disclose.
Steven Alberts, MD
Amanda L. Amin, MD
Hannah N. Bell, BS
Mitesh Borad, MD
Jennifer Boyer, APRN
Lifen Cao, MD, PhD
Xiuwen Deng, PhD
Peter G. Doukas, MD
Martin Fernandez-Zapico, MD
Nathan Foster, MS
Briant Fruth
Joshua W. Goyert, MS
Mindy Hartgers, APRN, CNP, MS
Tara L. Hogenson, MS
Ping Jiang, PhD
Weijuan Jiang, PhD
Stephen J. Kogut, PhD, MBA
James Martin, MD
Megan E. Miller, MD
Henry Pitot, MD
Gavino Puggioni, PhD, MS
Ang Qu, PhD
Priyanka Reddy, MD
Yatrik M. Shah, PhD
Robert Shenk, MD
Frederique St. Pierre, MD
Nickolas Stabellini, MS
Sri Harsha Tella, MBBS, FACP
Nguyen Tran, MD
Junjie Wang, PhD
Leslie Washburn, MPAS, PA-C
Jaclynn Wessling, MD
The faculty listed below have the following relevant financial relationship(s) with ineligible companies to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.
Zhaohui Jin, MD
Daiichi- Sankyo Co.: Scientific Advisor
Eli Lilly and Company: Scientific Advisor
GlaxoSmithKline: Scientific Advisor
Novartis Pharmaceuticals Corporation: Scientific Advisor
QED Therapeutics, Inc.: Scientific Advisor
Minetta Liu, MD
Eisai Inc.: Grant/Research Support
Exact Sciences: Grant/Research Support
Genentech, Inc.: Grant/Research Support
Genomic Health, Inc.: Grant/Research Support
GRAIL: Grant/Research Support
Menarini Silicon Biosystems: Grant/Research Support
Merck & Co., Inc.: Grant/Research Support
Novartis Pharmaceuticals Corporation: Grant/Research Support
Seattle Genetics, Inc.: Grant/Research Support
TESARO, Inc.: Grant/Research Support
Shuo Ma, MD, PhD
AbbVie, Inc.: Grant/Research Support; Scientific Advisor
AstraZeneca Pharmaceuticals LP: Consulting Fee; Grant/Research Support; Product/Speakers Bureau
BeiGene: Consulting Fee; Grant/Research Support; Product/Speakers Bureau
Janssen Pharmaceutica Products, LP: Consulting Fee; Grant/Research Support; Product/Speakers Bureau
Juno Therapeutics, Inc.: Grant/Research Support
Loxo Oncology, Inc.: Grant/Research Support
Pharmacyclics: Grant/Research Support; Product/Speakers Bureau
TG Therapeutics, Inc.: Consulting Fee; Grant/Research Support
Wen Wee Ma, MD
Actuate Therapeutics: Grant/Research Support
Athenex, Inc.: Grant/Research Support
BioMed Valley Discoveries: Grant/Research Support
Bristol-Myers Squibb Company: Grant/Research Support
Cardiff Oncology: Grant/Research Support
Genentech, Inc.: Grant/Research Support
Jacobio Pharmaceuticals: Grant/Research Support
Kodikaz Therapeutic Solutions: Equity Interest/Stock Options
Merus: Grant/Research Support
SunPharma Ltd: Grant/Research Support
Amit Mahipal, MD, MPH
AstraZeneca Pharmaceuticals LP: Honoraria
QED Therapeutics, Inc.: Honoraria
Robert McWilliams, MD
Zentalis Pharmaceuticals: Equity Interest/Stock Options
Alberto J. Montero, MD, MBA
AstraZeneca Pharmaceuticals LP: Product/Speakers Bureau
OncoSec Medical Incorporated.: Scientific Advisor
Qian Shi, PhD
Boehringer Ingelheim GmbH: Scientific Advisor
Bristol-Myers Squibb Company: Grant/Research Support
Chugai Pharmaceutical Co., Ltd: Honoraria
Genentech, Inc.: Grant/Research Support
Johnson & Johnson: Grant/Research Support
Naveris: Grant/Research Support
Regeneron Pharmaceuticals, Inc.: Consulting Fee
Roche Laboratories, Inc.: Grant/Research Support
Yiviva Inc.: Scientific Advisor
Christopher W. Towe, MD
AstraZeneca Pharmaceuticals LP: Consulting Fee
AtriCure, Inc.: Consulting Fee
Medtronic, Inc.: Scientific Advisor
Zimmer Biomet: Consulting Fee; Grant/Research Support; Intellectual Property Rights
Ami Vyas, PhD, MS, MBA
Merck & Co., Inc.: Grant/Research Support
Moderator
The faculty listed below have no relevant financial relationship(s) with ineligible companies to disclose.
Wui-Jin Koh, MD
NCCN Staff Disclosures
The planners listed below have the following relevant financial relationship(s) with ineligible companies to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.
Crystal Denlinger, MD, FACP
Agios, Inc.: Grant/Research Support
Amgen Inc.: Grant/Research Support
Astellas Pharma US, Inc.: Scientific Advisor
AstraZeneca Pharmaceuticals LP: Grant/Research Support
BeiGene: Scientific Advisor; Grant/Research Support
Bristol-Myers Squibb Company: Scientific Advisor; Grant/Research Support
Eli Lilly and Company: Grant/Research Support
Exelixis Inc.: Scientific Advisor; Grant/Research Support
Genmab: Grant/Research Support
MacroGenics: Grant/Research Support
MedImmune Inc: Grant/Research Support
Merck & Co., Inc.: Scientific Advisor
sanofi-aventis U.S.: Grant/Research Support
Taiho Pharmaceutials Co., Ltd.: Scientific Advisor
Zymeworks: Scientific Advisor; Grant/Research Support
Samantha L. Tamburro, RN, BSN, CPON
Flatiron Health, Inc.: Salary
None of the other planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
NCCN designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
NCCN designates this educational activity for a maximum of 1.0 contact hour.
Pharmacists
NCCN designates this knowledge-based continuing education activity for 1.0 contact hour (0.1 CEUs) of continuing education credit. UAN: JA4008196-0000-22-065-H01-P
Physician Assistants
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until March 1, 2023. PAs should only claim credit commensurate with the extent of their participation.
Available Credit
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 Participation
Price
Required Hardware/software
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability
- One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer is no longer supported
- Adobe Reader or other PDF reader software for certificate viewing/printing